West Pharmaceutical (WST) Tops Q4 EPS by 5c; Issues Strong FY13 Outlook
Tweet Send to a Friend
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.61, $0.05 better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
